Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mesenchymal Stem Cell-Secreted Factors (Paracrine Secretome) (MSC Secretome)
- Target
- MSC Secretome
- Molecular classification
- Cytokines, Chemokines, Growth Factors, Extracellular Vesicles, Lipid Mediators, Enzymes
01
Overview
The mesenchymal stem cell (MSC) secretome encompasses a complex mixture of bioactive molecules, including cytokines, chemokines, growth factors, and extracellular vesicles, released by MSCs through paracrine signaling. This secretome orchestrates potent immunomodulatory actions across multiple arms of the immune system, influencing both innate and adaptive immune responses. Its effects are mediated through indirect intercellular communication pathways, impacting a wide array of immune cell types, including T lymphocytes, B lymphocytes, dendritic cells, natural killer cells, macrophages, and neutrophils. The MSC secretome's ability to fine-tune immunity makes it a promising therapeutic approach for various conditions involving immune dysregulation.
- Other names
- MSC-derived factorsMSC secretomeMesenchymal Stromal Cell-Secreted FactorsMedicinal Signaling Cell-derived factorsMSC paracrine signaling molecules
02
Mechanism of action
Multiple mechanisms including receptor binding, intracellular signaling modulation via secreted factors, and cellular reprogramming through extracellular vesicles
03
Biological functions
ImmunomodulationAnti-inflammationTissue RepairAngiogenesisCell signalingT cell suppressionMacrophage polarizationDendritic cell tolerizationB cell suppressionNK cell modulation
04
Disease associations
Autoimmune DiseasesGraft-versus-host DiseaseInflammationTransplantationWound HealingImmunodeficiencyCancer
05
Safety considerations
Variability in MSC potency and consistencyPotential for off-target effects on the immune systemRisk of promoting tumor growth in certain contextsDelivery challenges and biodistribution of secreted factorsImmunogenicity of MSCs
06
Interacting drugs
Not applicable - complex mixture, not a single target
07
Biomarkers
Levels of specific cytokines (e.g., IL-10, TGF-β) in MSC-conditioned media or patient samplesmiRNA profiles in MSC-derived exosomesChanges in immune cell populations (e.g., regulatory T cells)Reduction of pro-inflammatory markers (e.g., TNF-α, IL-6)Improvement in disease-specific clinical outcomes
Beyond the preview
Go deeper on Mesenchymal Stem Cell-Secreted Factors (Paracrine Secretome) (MSC Secretome).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mesenchymal Stem Cell-Secreted Factors (Paracrine Secretome) (MSC Secretome).